Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04623359
Other study ID # 2014/047/HP
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2021
Est. completion date September 2024

Study information

Verified date November 2020
Source University Hospital, Rouen
Contact Guillaume GOURCEROL, Pr
Phone 02 32 88
Email guillaume.gourcerol@chu-rouen.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Constipation is a frequent symptom that is reported by more than 10% of the general population. In a few case, constipation is resistant to medical standard care, including osmotic and stimulant laxatives. The diagnosis of colonic inertia may be suspected in these patients although diagnostic criteria for colonic inertia may vary from one country to another. In France, the diagnosis of colonic inertia is based on manometric study of the colorectal contractile activity using manometric probe. Using conventional manometric catheters, severe alteration of the colorectal motility is found in a very small subset of patients, who may later benefit from surgery. The recent use of high resolution manometric probe allowed to map more precisely colorectal motility, but whether these new parameters are relevant remains to be assessed. The aim of this study is to assess the diagnostic performance of a new high resolution manometric probe by comparing healthy volunteers to patients suspected of colonic inertia.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 76
Est. completion date September 2024
Est. primary completion date September 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility For patient Inclusion Criteria: - Age between 18 and 65 years - chronic Constipation (> 6 months) - delayed colonic transit time > 100 h - normal colonoscopy - constipation refractory to at least 1 osmotic and 1 stimulant laxative according French guidelines on constipation ; - Affiliated to French national healthcare insurance Exclusion Criteria: - Patient with constipation being either: - With colonic transit time <100h - Distal (with radio-opaque markers stasis in the rectum) - From organic origin - Recent (<6 mois) - Relieved using osmotic or stimulant laxatives - Contra-indication to the use of high resolution manometry insertion - Intestinal occlusion - Coagulation disorders, including anti-coagulant treatments - General anesthesia contra-indication - colonoscopy contra-indication - failure to perform a colonoscopy in previous attempts - medication intake that may impair colorectal motility, including opioids - Evolutive inflammatory of neoplasia process - History of major digestive surgery (at exclusion of appendicectomy, cholecystectomy) - Presence of condition that may impact digestive motility, including diabetes mellitus and sclerodermia - Cardiologic disease that may represent a contraindication to vagal stimulation For Healthy volunteers Inclusion Criteria: - Age between 18 and 65 years - Affiliated to French national healthcare insurance Exclusion Criteria: - Significant digestive evolutive disease - constipation with Kess score > 11/39 and colonic transit time = 60 h - Contra-indication to the use of high resolution manometry insertion - Intestinal occlusion - Cardiac disease - Coagulation disorders, including anti-coagulant treatments - General anesthesia contra-indication - colonoscopy contra-indication - History of major digestive surgery (at exclusion of appendicectomy, cholecystectomy) - Presence of condition that may impact digestive motility, including diabetes mellitus and sclerodermia

Study Design


Related Conditions & MeSH terms


Intervention

Device:
High resolution manometry
High resolution manometry

Locations

Country Name City State
France Rouen University Hospital Rouen

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Rouen

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of isolated propagated colonic contractions Number of colonic contractions during 24 hours 24 hours
Secondary Speed of isolated propagated colonic contractions Average speed of colonic contractions during 24 hours 24 hours
Secondary Colonic transit time Transit time will be measured during during the first 24 hours during the first 24 hours
See also
  Status Clinical Trial Phase
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Recruiting NCT06292949 - Clinical Study of Resistant Starch in Improving Constipation N/A
Recruiting NCT04132661 - MRI Assessment of Mode of Action of Bisacodyl, Single Dose Phase 4
Terminated NCT02839889 - Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) Phase 4
Completed NCT02726295 - The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study Phase 4
Recruiting NCT02255747 - Anal Dilatation for Infants and Children With Constipation N/A
Completed NCT02246647 - Biomarkers for Intestinal Permeability in Patients With Constipation
Completed NCT01566409 - Maintenance Treatment for Children With Constipation N/A
Completed NCT02863848 - Effect of Inulin-type Fructans on Constipated Children. N/A
Completed NCT02658201 - Ultrafast MRI Imaging to Exclude Constipation N/A
Completed NCT01710579 - Normal Values in Ano-rectal 3D High Resolution Manometry N/A
Completed NCT01695915 - Diurnal Variation in Rectal Diameter N/A
Completed NCT01474499 - A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation Phase 3
Completed NCT01411501 - Efficacy and Safety of Acupuncture for Functional Constipation Phase 3
Completed NCT01438567 - A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy Phase 3
Completed NCT00931853 - Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC). Phase 3
Completed NCT01170039 - The Effectiveness of Lubiprostone in Constipated Diabetics Phase 4
Active, not recruiting NCT02442115 - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Terminated NCT01003249 - Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen Phase 4
Completed NCT00994851 - Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment. Phase 3